Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Raymond James Financial heads into its July 22 earnings release with the Street broadly constructive, short sellers retreating, and options traders unusually calm — a setup that leaves little room for disappointment.
The positioning story is notably uncrowded on the bearish side. Short interest has fallen nearly 6% over the past week to 5.0% of free float, continuing a month-long unwind that has trimmed roughly 7% from the short book. Borrow conditions reinforce that picture: availability runs at 1,547% — more than fifteen shares available for every one currently lent out — meaning there is no structural pressure forcing shorts to cover. Cost to borrow is a negligible 0.40%. Options traders are equally relaxed, with the put/call ratio at 0.32, slightly below its 20-day average and nowhere near the defensive posturing that typically precedes an anxious print. Together, the lending and options data describe a market leaning into this report rather than hedging against it.
Analysts sharpened their targets aggressively in the days before the report. Barclays lifted its Overweight target to $192, Citizens raised its Market Outperform to $200, and Morgan Stanley nudged its Equal-Weight target to $174 — all within the past ten days. The consensus sits at Hold with a mean target of $182.67, roughly 8.5% above the current price of $168.36, which has itself gained 6.3% over the past month. Bulls point to Raymond James's wealth management scale, NNA growth, and a business mix that insulates it from pure credit-cycle swings. Bears counter that EPS estimates trail consensus and that valuation leaves limited upside: at 12.9x trailing earnings and 2.4x book, the stock is cheap versus peers like SCHW at 18.6x — but the discount may reflect structural differences rather than mispricing. Forward EPS momentum ranks in the 92nd percentile on a 12-month basis, a genuinely strong reading, though EPS surprise history is a more modest 58th percentile.
One note of caution comes from the earnings history. The May 2026 print delivered a one-day drop of 6.7%, the sharpest negative reaction on record in the available data, suggesting the stock can be punished when results or guidance disappoint even modestly. Peers have had a good week — LPLA, AMP, SF, and CG all closed the week up 2–4%, while SCHW was the lone laggard, down 1.5% — giving RJF a broadly supportive sector backdrop but also raising the bar for relative performance.
The print will test whether the earnings acceleration implied by that 92nd-percentile forward EPS momentum estimate can actually materialise at a margin profile that justifies the run-up — or whether, as happened in May, a fine result simply fails to clear the expectations already baked into the stock.
See the live data behind this article on ORTEX.
Open RJF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
